{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:35:10Z","timestamp":1786653310716,"version":"build-2736575974"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol India"],"published-print":{"date-parts":[[2015]]},"DOI":"10.4103\/0028-3886.152687","type":"journal-article","created":{"date-parts":[[2015,3,4]],"date-time":"2015-03-04T02:33:52Z","timestamp":1425436432000},"page":"120","source":"Crossref","is-referenced-by-count":4,"title":["Reversible onychomadesis following exposure to carbamazepine"],"prefix":"10.4103","volume":"63","author":[{"given":"NeerajN","family":"Baheti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Kabra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NitinH","family":"Chandak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BD","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RajeshR","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0028-3886.152687-1","first-page":"250","volume-title":"Nail changes secondary to systemic drugs","author":"Damel","year":"1984","journal-title":"J Am Acad Deratol"},{"key":"key-10.4103\/0028-3886.152687-2","unstructured":"Silverman R, Baran R. Nail and appendageal abnormalities. In: Schachner LA, Hansen RC, editors. Pediatric Dermatology. Edinburgh: Mosby; 2003. p. 561-87."},{"key":"key-10.4103\/0028-3886.152687-3","first-page":"460","volume-title":"Possible carbamazepine induced reversible onychomadesis","author":"Mishra","year":"1989","journal-title":"Int J Dermatol"},{"key":"key-10.4103\/0028-3886.152687-4","first-page":"256","volume-title":"Reversible onychomadesis induced by carbamazepine","author":"Prabhakara","year":"1996","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/0028-3886.152687-5","first-page":"64","volume-title":"Generalized onycholysis associated with sodium valproate therapy","author":"Grech","year":"1999","journal-title":"Eur Neurol"},{"key":"key-10.4103\/0028-3886.152687-6","first-page":"103","volume-title":"Nail changes after carbamazepine","author":"Chopra","year":"2000","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/0028-3886.152687-7","first-page":"14","volume-title":"Carbamazepine-induced reversible onychomadesis: A case report","author":"Yasushi","year":"2005","journal-title":"J Japan Epilepsy Soc"},{"key":"key-10.4103\/0028-3886.152687-8","first-page":"P227","volume-title":"A case of carbamazepine induced onychomadesis","author":"You","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"key-10.4103\/0028-3886.152687-9","first-page":"89","volume-title":"Stevens-Johnson syndrome induced by carbamazepine","author":"Czajkowski","year":"2007","journal-title":"Acta Pol Pharm"},{"key":"key-10.4103\/0028-3886.152687-10","first-page":"749","volume-title":"Onychomadesis: A rare side-effect of valproic acid medication?","author":"Poretti","year":"2009","journal-title":"Pediatr Dermatol"},{"key":"key-10.4103\/0028-3886.152687-11","first-page":"79","volume-title":"Onychomadesis: A new side effect of sodium valproate therapy in children?","author":"Icagasioglu","year":"2011","journal-title":"Arch Neuropsychiatry"},{"key":"key-10.4103\/0028-3886.152687-12","first-page":"522","volume-title":"Finger-nail onycholysis, leukonychia and acrocyanosis in a patient treated with valproic acid - Case report","author":"Jenerowicz","year":"2011","journal-title":"Postepy Dermatol Alergol"},{"key":"key-10.4103\/0028-3886.152687-13","first-page":"7","volume-title":"Nail matrix arrest following hand-foot-mouth disease: A report of five children","author":"Clementz","year":"2000","journal-title":"Pediatr Dermatol"},{"key":"key-10.4103\/0028-3886.152687-14","unstructured":"Convey JM, Kriel RL, Birnbaun AK. Antiepileptic drug therapy in children. In: Swaiman KF, Ashwal S, Ferriero DM, editors. Pediatric Neurology Principles and Practice. 4 th ed. Philadelphia: Mosby; 2006. p. 1122-5."},{"key":"key-10.4103\/0028-3886.152687-15","first-page":"1661","volume-title":"Pattern of malformations in the children of women treated with carbamazepine during pregnancy","author":"Jones","year":"1989","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0028-3886.152687-16","first-page":"603","volume-title":"Cutaneous manifestations of zinc deficiency during treatment with anticonvulsants","author":"Lewis-Jones","year":"1985","journal-title":"Br Med J (Clin Res Ed)"},{"key":"key-10.4103\/0028-3886.152687-17","first-page":"117","volume-title":"Serum and hair zinc levels in epileptic children taking valproic acid","author":"Altunbasak","year":"1997","journal-title":"Biol Trace Elem Res"}],"container-title":["Neurology India"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:35:11Z","timestamp":1786649711000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0028-3886.152687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015]]}},"alternative-id":["152687"],"URL":"https:\/\/doi.org\/10.4103\/0028-3886.152687","relation":{},"ISSN":["0028-3886"],"issn-type":[{"value":"0028-3886","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}